#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma refractory Metastases to peritoneum Primary mediastinal large B-cell lymphoma Acute promyelocytic leukaemia Ewing's sarcoma recurrent Anti-myelin-associated glycoprotein associated polyneuropathy Immunodeficiency congenital Germ cell cancer Adrenogenital syndrome Transplant rejection Hereditary haemorrhagic telangiectasia Metastases to central nervous system Squamous cell carcinoma of the cervix Tourette's disorder Astrocytoma More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Trials in Disease Hypereosinophilic syndrome – Diagnostics Proteus syndrome Marginal zone lymphoma refractory – Basic Information Myxofibrosarcoma – Basic Information Undifferentiated sarcoma – Basic Information Lennox-Gastaut syndrome – Basic Information Rhabdomyosarcoma Haemophilia – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Regtivex Venglustat Levosimendan Pantoprazole Danicamtiv Zanubrutinib PROMESTRIENE Valproate Semisodium Corticosteroids, Plain Deferoxamine Mesilate GSKVX000000034798 Colestyramine Imipenem Int-787 Ng004 R2R01 [18F]CPFPX Acasunlimab Edoxaban Trabectedin More therapies…

    Learn about Your Condition

    Blood iron increased Radicular pain Polycystic ovarian syndrome Alcoholic liver disease Facial paresis Diabetic foot infection Gastrectomy Aortic aneurysm Brain cancer metastatic Inborn error of metabolism Small intestine adenocarcinoma Idiopathic pulmonary fibrosis Coronary artery dissection Procedural anxiety Eye pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mwuhaj Zalbeshb Kvzho 2qi Dbaamudvo 4rfme Hdpfuqw

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Oral Azacitidine and Cedazuridine with Subcutaneous Azacitidine for Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myelomonocytic leukaemia
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Azacitidine
    • Cedazuridine
    Czechia France Germany Hungary Italy Poland +1

  • Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tezepelumab
    Belgium Bulgaria Denmark France Greece Hungary +3

  • Study of mRNA-4157 and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Mrna-4157
    Denmark France Germany Greece Hungary Italy +3

  • Study on Tozorakimab for Adults with Uncontrolled Asthma Using Medium-to-High Dose Inhaled Corticosteroids

    Recruiting

    2 1 1
    Investigated Drugs:
    • Tozorakimab
    • Salbutamol Sulfate
    France Greece Hungary Italy Spain

  • Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Czechia Denmark France Germany Greece +8

  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments

    Recruiting

    3 1
    Investigated Drugs:
    • Jnj-77242113
    Bulgaria Czechia Denmark Germany Hungary Italy +3

  • Study on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    • Lisaftoclax
    • Azacitidine
    Belgium Bulgaria Czechia Finland France Germany +7

  • Comparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    • Pain
    Investigated Drugs:
    • CHONDROITIN SULFATE SODIUM
    Czechia Hungary Poland

  • Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

    Recruiting

    3 1
    Investigated Drugs:
    • Elritercept
    Bulgaria Czechia France Germany Hungary Ireland +5

  • Study of Sacituzumab Tirumotecan and Bevacizumab for Patients with Recurrent Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer recurrent
    • Ovarian cancer recurrent
    Investigated Drugs:
    • Bevacizumab
    • Buclizine Hydrochloride
    • Codeine Phosphate
    Austria Belgium Czechia Denmark Finland France +8
Previous Page
1 … 9 10 11 12 13 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!